Ascend Wellness Earnings Estimate

Ascend Wellness Earnings per Share Projection vs Actual

About Ascend Wellness Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Ascend Wellness earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Ascend Wellness estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Ascend Wellness fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. The company was incorporated in 2018 and is headquartered in New York, New York. Ascend Wellness operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1800 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Ascend OTC Stock

Ascend Wellness financial ratios help investors to determine whether Ascend OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ascend with respect to the benefits of owning Ascend Wellness security.